Q1 EPS Estimates for AstraZeneca Lowered by Leerink Partnrs
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Equities researchers at Leerink Partnrs decreased their Q1 2025 EPS estimates for AstraZeneca in a research report issued to clients and investors on Monday, February 10th. Leerink Partnrs analyst A. Berens now expects that the company will earn $1.11 per share for the quarter, down from their previous […]
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Equities researchers at Leerink Partnrs decreased their Q1 2025 EPS estimates for AstraZeneca in a research report issued to clients and investors on Monday, February 10th. Leerink Partnrs analyst A. Berens now expects that the company will earn $1.11 per share for the quarter, down from their previous […]